Skip to main content
Clinical Trials/NCT07652177
NCT07652177CompletedNot Applicable

Comparison of the Analgesic Efficacy of Lumbar Erector Spinae Plane Block and Sacral Erector Spinae Plane Block in Lumbar Microdiscectomy Surgeries

Gaziosmanpasa Research and Education Hospital1 site in 1 country88 target enrollmentStarted: May 15, 2025Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
88
Locations
1
Primary Endpoint
total tramadol consumption

Study Overview

Brief Summary

Comparison of the Analgesic Efficacy of Lumbar Erector Spinae Plane Block and Sacral Erector Spinae Plane Block in Lumbar Microdiscectomy Surgeries

Detailed Description

Postoperative pain is commonly observed in patients undergoing lumbar microdiscectomy surgery.

To manage this pain, the lumbar erector spinae plane (ESP) block is frequently administered as part of a multimodal analgesia regimen, particularly with the aim of reducing opioid consumption in these patients.

Recent publications have demonstrated the analgesic efficacy of the sacral erector spinae plane block in lumbar microdiscectomy surgeries.

In this study, the postoperative analgesic effectiveness of the lumbar ESP block-performed two vertebral levels above the surgical site-will be compared with that of the sacral ESP block-performed two vertebral levels below the surgical site.

It is anticipated that this approach will provide effective analgesia while avoiding the use of opioids.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • ASA I, ASA II, and ASA III patients scheduled for single-level lumbar microdiscectomy at the L4-L5 or L5-S1 level.

Exclusion Criteria

  • Pregnant patients
  • Patients who do not consent to the erector spinae plane block
  • Patients requiring mechanical ventilatory support
  • Patients with a history of substance abuse
  • Patients with a known allergy to the medications to be used
  • Patients with bleeding diathesis
  • Patients with infection at the planned block site
  • Patients undergoing surgical intervention at two or more spinal levels
  • Patients with communication difficulties or intellectual disabilities
  • Patients with neuropsychiatric disorders
  • Patients with chronic pain
  • Patients with an expected surgical duration of 180 minutes or more
  • Patients with a prior history of lumbar microdiscectomy

Arms & Interventions

lumbar ESP

sacral ESP

Outcomes

Primary Outcomes

total tramadol consumption

Time Frame: first 24 hours after the surgery

Secondary Outcomes

  • patients' visual analog scale(first 24 hours after the surgery)
  • To compare analgesic consumption during the postoperative time intervals of 0-2, 2-4, 4-8, 8-12, and 12-24 hours.(first 24 hours after the surgery)

Investigators

Sponsor Class
Other Gov
Responsible Party
Principal Investigator
Principal Investigator

SERPİL ŞEHİRLİOĞLU

specialist

Gaziosmanpasa Research and Education Hospital

Study Sites (1)

Loading locations...

Similar Trials